Greece vs United States of America: Previously treated cases tested for RR-/MDR-TB
Greece
84.0%
in 2024
United States of America
83.0%
in 2023
Greece rank
103rd
United States of America rank
104th
Previously treated cases tested for RR-/MDR-TB over time
- Greece
- United States of America
How they compare
Greece currently reports 84.0% against 83.0% in United States of America, a difference of 1.0%.
The two have swapped places 2 times across 11 shared years of data; in 2013 it was United States of America ahead.
Greece ranks 103rd and United States of America ranks 104th of 180 countries.
United States of America has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Greece | United States of America | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 43.7% | 70.6% | 26.9% | United States of America |
| 2020s | 65.2% | 84.8% | 19.5% | United States of America |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Greece or United States of America?
- Greece, at 84.0% against 83.0% in United States of America as of 2024.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Greece and United States of America?
- 1.0%, with Greece ahead.
- How many years of comparable data are there for Greece and United States of America?
- 11 years are reported by both, from 2013 to 2023.
- How do Greece and United States of America rank globally for previously treated cases tested for rr-/mdr-tb?
- Greece ranks 103rd and United States of America ranks 104th of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.